USPTO serial 87660571
V-CHECK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 29, 2019
- Examiner
- HALMEN, KATHERINE E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with V-CHECK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Hsinchu County, TW
Hsinchu County 30261, TW
Hsinchu County 30261, TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, 20015JAPANGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents for immune enhancement; drugs for human, namely, pharmaceutical preparations for reproductive medicine, women health, cirrhosis, hepatitis; contrast media for clinical diagnosis for medical use; contrast agent for clinical application, namely, contrast agent in the nature of contrast media for medical use for use in immunoassay, in vitro diagnostic kits and clinical medical reagents; bio-reagent for clinical applications, namely, immunoassay in the nature of medical diagnostic assays for testing of body fluids, in vitro diagnostic kit comprised of medical diagnostic assays for testing of body fluids, and clinical medical reagent; chemical agent for clinical applications, namely, immunoassay in the nature of medical diagnostic assays for testing of body fluids, in vitro diagnostic kit comprised of medical diagnostic assays for testing of body fluids, and clinical medical reagent; radiographic x-ray contrast agent; protease for clinical applications, namely, protease enzymes for medical purposes for use in reproductive medicine, women health, cirrhosis, and hepatitis; vaccine; chemical agents namely, immunoassay in the nature of medical diagnostic assays for testing of body fluids, in vitro diagnostic kit comprised of medical diagnostic assays for testing of body fluids, and clinical medical reagent; adjuvant for medical purposes for clinical applications; medicinal preparations for prevention and treatment of reproductive medical conditions, women's health conditions, cirrhosis, and hepatitis; pregnancy test kits for home use and clinical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection in the fields of reproductive medicine, women health, cirrhosis, hepatitis; chemical drugs for clinical applications, namely, pharmaceutical preparations for reproductive medicine, women health, cirrhosis, hepatitis; diagnostic kit comprised of medical diagnostic reagents and assays that test for the presence of reproductive medical conditions, women's health conditions, cirrhosis, hepatitis; diagnostic test for disease related biomarkers, namely, protein arrays for medical diagnosis purposes in the nature of alpha 1 antitrypsin and alpha 1 antitrypsin isoforms and the peptides derived from alpha 1 antitrypsin, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, detecting reproductive diseases, women's health conditions, cirrhosis, hepatitis; clinical medical reagents for diagnostic test; test strip for clinical applications, namely, medical diagnostic test strips for use in the field of reproductive medicine, women's health, cirrhosis, hepatitis; sanitary pads | SECTION 8 - CANCELLED | Jun 3, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 15, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 29, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 21, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 21, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Jul 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 10, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Jul 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 10, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 10, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 29, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 21, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 20, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 20, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 19, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 26, 2019 | IUAF | USE AMENDMENT FILED | — |
| Aug 26, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 4, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 4, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 4, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 9, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 5, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 5, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 7, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 4, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2017 | NWAP | NEW APPLICATION ENTERED | — |